Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report)’s share price hit a new 52-week high during trading on Monday . The stock traded as high as GBX 2,166 ($26.95) and last traded at GBX 2,166 ($26.95), with a volume of 279808 shares trading hands. The stock had previously closed at GBX 2,130 ($26.50).
Hikma Pharmaceuticals Trading Up 1.0 %
The company has a 50 day moving average price of GBX 1,985.91 and a 200 day moving average price of GBX 1,942.11. The company has a debt-to-equity ratio of 55.48, a quick ratio of 1.27 and a current ratio of 1.66. The firm has a market cap of £4.96 billion, a price-to-earnings ratio of 3,436.92, a price-to-earnings-growth ratio of 2.38 and a beta of 0.41.
About Hikma Pharmaceuticals
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
Read More
- Five stocks we like better than Hikma Pharmaceuticals
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Investing in Commodities: What Are They? How to Invest in Them
- What Does the Future Hold for Eli Lilly?
- What is the Shanghai Stock Exchange Composite Index?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
